Kiniksa Pharmaceuticals, Ltd. KNSA
$ 21.04
-0.8%
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 29.10.2024
Kiniksa Pharmaceuticals, Ltd. Мультипликаторы 2011-2024 | KNSA
Мультипликаторы по годам Kiniksa Pharmaceuticals, Ltd.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
101.5 | 4.7 | -4.9 | -7.5 | -4.9 | -8.8 | - | - | - | - | - | - | - |
P/S |
5.3 | 3.9 | 20.0 | - | - | - | - | - | - | - | - | - | - |
EPS |
0.2 | 2.6 | -2.3 | -2.6 | -3.0 | -3.5 | -35.9 | - | - | - | - | - | - |
EV (Enterprise Value) |
1.41 млрд | 809 млн | 695 млн | 1.14 млрд | 782 млн | 874 млн | 91.5 млн | 82.2 млн | - | - | - | - | - |
EBITDA per Share |
-0.33 | 0.18 | -2.25 | -2.51 | -3.11 | -2.18 | - | - | - | - | - | - | - |
EV/EBITDA |
-4.4 | -8.0 | -4.5 | -7.7 | - | - | - | - | - | - | - | ||
PEG |
- | 27.67 | -0.11 | 0.37 | - | - | - | - | - | - | - | ||
P/B |
3.3 | 2.2 | 4.2 | 3.9 | 3.5 | 3.2 | - | - | - | - | - | - | - |
P/CF |
107.5 | 149.5 | -6.1 | -8.9 | -5.0 | -10.5 | - | - | - | - | - | - | - |
ROE % |
3.21 | 46.29 | -85.35 | -51.74 | -71.81 | -36.96 | - | - | - | - | - | - | - |
ROA % |
2.68 | 39.89 | -67.84 | -46.18 | -63.59 | -32.06 | - | - | - | - | - | - | - |
ROCE % |
-5.74 | 2.47 | -84.65 | -50.45 | -74.97 | -38.71 | - | - | - | - | - | - | - |
Current Ratio |
6.0 | 7.2 | 4.9 | 9.3 | 8.7 | 7.4 | - | - | - | - | - | - | - |
DSO |
22.9 | 13.8 | 18.9 | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
22.9 | 13.8 | 18.9 | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
22.9 | 13.8 | 18.9 | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Kiniksa Pharmaceuticals, Ltd.
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.18 | -0.06 | -0.25 | -0.2 | 0.21 | -0.18 | - | 3.23 | -0.29 | -0.36 | - | -0.44 | -0.61 | -0.72 | - | -0.66 | -0.65 | -0.48 | - | -0.49 | -0.68 | -1.27 | - | -0.51 | -1.11 | -6.45 | - | -8.25 | -6.69 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.13 | - | -0.23 | -0.15 | -0.04 | -0.15 | - | 0.67 | -0.27 | -0.33 | - | -0.42 | -0.59 | -0.72 | - | -0.63 | -0.53 | -0.52 | - | -0.55 | -0.71 | -1.3 | - | -0.54 | -1.17 | -6.59 | - | -8.36 | -6.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-11.32 | -4.78 | -7.03 | 55.43 | 117.20 | 100.55 | 30.17 | 15.90 | -56.72 | -61.33 | -50.18 | -64.23 | -64.01 | -58.40 | -34.53 | -46.54 | -44.49 | -48.97 | -57.70 | -66.44 | -63.18 | -53.93 | -21.72 | -3.85 | 22.76 | 42.50 | 30.36 | 30.36 | 12.49 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-9.28 | -3.90 | -5.95 | 46.17 | 97.76 | 83.76 | 26.89 | 14.81 | -35.07 | -49.96 | -42.87 | -55.41 | -55.88 | -51.71 | -30.83 | -41.46 | -39.54 | -43.43 | -51.10 | -58.68 | -55.63 | -47.31 | -18.84 | -52.59 | -78.76 | -96.06 | -57.34 | -57.34 | -23.59 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-8.76 | -7.32 | -10.16 | 5.75 | 20.54 | 8.68 | -14.56 | -28.89 | -55.30 | -59.88 | -49.73 | -63.59 | -63.12 | -56.13 | -33.49 | -47.00 | -46.65 | -53.86 | -60.94 | -70.31 | -66.17 | -56.45 | -22.93 | -4.81 | 22.67 | 43.07 | 30.81 | 30.81 | 12.70 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
4.7 | 5.0 | 5.9 | 6.2 | 6.7 | 8.4 | 7.2 | 6.1 | - | 3.6 | 4.9 | 6.5 | 6.4 | 7.7 | 9.3 | 9.3 | 9.3 | 9.3 | 8.7 | 8.7 | 8.7 | 8.7 | 7.5 | 7.5 | 7.5 | 7.5 | 2.7 | 2.7 | 2.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
18.4 | 15.3 | 10.9 | 18.8 | 20.5 | 18.9 | - | 5.1 | 49.8 | 47.4 | - | 21.8 | 15.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
144.2 | 230.1 | 227.9 | 248.7 | 280.8 | 292.0 | - | 96.2 | 120.0 | - | - | 197.7 | 158.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
35.7 | 48.2 | 28.6 | 8.3 | 12.1 | 60.2 | - | 9.7 | 30.7 | - | - | 95.7 | 128.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
162.6 | 245.4 | 238.8 | 267.6 | 301.3 | 310.9 | - | 101.3 | 169.8 | 47.4 | - | 219.4 | 173.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
126.9 | 197.2 | 210.1 | 259.2 | 289.2 | 250.7 | - | 91.6 | 139.1 | 47.4 | - | 123.7 | 45.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD